1. Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther. 2007; 25:599–608.
2. Eoff JC. Optimal treatment of chronic constipation in managed care: review and roundtable discussion. J Manag Care Pharm. 2008; 14:9 Suppl A. 1–15.
3. Ewe K, Ueberschaer B, Press AG, Kurreck C, Klump M. Effect of lactose, lactulose and bisacodyl on gastrointestinal transit studied by metal detector. Aliment Pharmacol Ther. 1995; 9:69–73.
4. Kienzle-Horn S, Vix JM, Schuijt C, Peil H, Jordan CC, Kamm MA. Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-blind, randomized, placebo-controlled study. Aliment Pharmacol Ther. 2006; 23:1479–1488.
5. Kamm MA, Mueller-Lissner S, Wald A, Richter E, Swallow R, Gessner U. Oral bisacodyl is effective and well-tolerated in patients with chronic constipation. Clin Gastroenterol Hepatol. 2011; 9:577–583.
6. Saunders DR, Haggitt RC, Kimmey MB, Silverstein FE. Morphological consequences of bisacodyl on normal human rectal mucosa: effect of a prostaglandin E1 analog on mucosal injury. Gastrointest Endosc. 1990; 36:101–104.
7. Geboes K. Laxatives and intestinal epithelial cells: a morphological study of epithelial cell damage and proliferation. Verh K Acad Geneeskd Belg. 1995; 57:51–74.
8. Kacere RD, Srivatsa SS, Tremaine WJ, Ebnet LE, Batts KP. Chronic diarrhea due to surreptitious use of bisacodyl: case reports and methods for detection. Mayo Clin Proc. 1993; 68:355–357.
9. Meisel JL, Bergman D, Graney D, Saunders DR, Rubin CE. Human rectal mucosa: proctoscopic and morphological changes caused by laxatives. Gastroenterology. 1977; 72:1274–1279.
10. Ikarashi N, Baba K, Ushiki T, Kon R, Mimura A, Toda T, et al. The laxative effect of bisacodyl is attributable to decreased aquaporin-3 expression in the colon induced by increased PGE2 secretion from macrophages. Am J Physiol Gastrointest Liver Physiol. 2011; 301:G887–G895.
11. Ajani S, Hurt RT, Teeters DA, Bellmore LR. Ischaemic colitis associated with oral contraceptive and bisacodyl use. BMJ Case Rep. 2012; 2012:DOI:
10.1136/bcr-12-2011-5451.
12. Demirci H, Ozturk K, Kantarcioglu M, Uygun A, Bagci S. Solitary rectal ulcer syndrome in an elderly adult. J Am Geriatr Soc. 2015; 63:1270–1271.
13. Zhu QC, Shen RR, Qin HL, Wang Y. Solitary rectal ulcer syndrome: clinical features, pathophysiology, diagnosis and treatment strategies. World J Gastroenterol. 2014; 20:738–744.
14. Chiang JM, Changchien CR, Chen JR. Solitary rectal ulcer syndrome: an endoscopic and histological presentation and literature review. Int J Colorectal Dis. 2006; 21:348–356.